AAAAAA

   
Results: 1-25 | 26-29
Results: 1-25/29
Human gamma delta T cells express a higher TCR/CD3 complex density than alpha beta T cells
Authors: Nicolas, L Monneret, G Debard, AL Blesius, A Gutowski, MC Salles, G Bienvenu, J
Citation: L. Nicolas et al., Human gamma delta T cells express a higher TCR/CD3 complex density than alpha beta T cells, CLIN IMMUNO, 98(3), 2001, pp. 358-363
Inter-laboratory evaluation of the COBAS INTEGRA (R) 400 analytical system
Authors: Muser, J Bienvenu, J Blanckaert, N Brandslund, I Delattre, J Soffiati, G Swaminathan, R Maggini, S Mastall, H
Citation: J. Muser et al., Inter-laboratory evaluation of the COBAS INTEGRA (R) 400 analytical system, CLIN CH L M, 39(6), 2001, pp. 539-559
Drug-induced urticaria
Authors: Cousin, F Philips, K Favier, B Bienvenu, J Nicolas, JF
Citation: F. Cousin et al., Drug-induced urticaria, EUR J DERM, 11(3), 2001, pp. 181-187
High circulating tumor necrosis factor levels correlate with increased levels of soluble CD14 in patients with non-Hodgkin's lymphoma
Authors: Baseggio, L Charlot, C Picollet, J Bienvenu, J Salles, G
Citation: L. Baseggio et al., High circulating tumor necrosis factor levels correlate with increased levels of soluble CD14 in patients with non-Hodgkin's lymphoma, HAEMATOLOG, 86(7), 2001, pp. 774-775
Higher LPS-stimulated TNF-alpha mRNA levels in peripheral blood mononuclear cells from non-Hodgkin's lymphoma patients
Authors: Baseggio, L Bienvenu, J Charlot, C Picollet, J Felman, P Coiffier, B Salles, G
Citation: L. Baseggio et al., Higher LPS-stimulated TNF-alpha mRNA levels in peripheral blood mononuclear cells from non-Hodgkin's lymphoma patients, EXP HEMATOL, 29(3), 2001, pp. 330-338
Procalcitonin as an acute phase marker
Authors: Whicher, J Bienvenu, J Monneret, G
Citation: J. Whicher et al., Procalcitonin as an acute phase marker, ANN CLIN BI, 38, 2001, pp. 483-493
The clinical usefulness of the measurement of cytokines
Authors: Bienvenu, J Monneret, G Fabien, N Revillard, JP
Citation: J. Bienvenu et al., The clinical usefulness of the measurement of cytokines, CLIN CH L M, 38(4), 2000, pp. 267-285
Procalcitonin and calcitonin gene-related peptide decrease LPS-induced TNFproduction by human circulating blood cells
Authors: Monneret, G Pachot, A Laroche, B Picollet, J Bienvenu, J
Citation: G. Monneret et al., Procalcitonin and calcitonin gene-related peptide decrease LPS-induced TNFproduction by human circulating blood cells, CYTOKINE, 12(6), 2000, pp. 762-764
Factors that predict chemotherapy-induced myelosuppression in lymphoma patients: Role of the tumor necrosis factor ligand-receptor system
Authors: Voog, E Bienvenu, J Warzocha, K Moullet, I Dumontet, C Thieblemont, C Monneret, G Gutowski, MC Coiffier, B Salles, G
Citation: E. Voog et al., Factors that predict chemotherapy-induced myelosuppression in lymphoma patients: Role of the tumor necrosis factor ligand-receptor system, J CL ONCOL, 18(2), 2000, pp. 325-331
Expression of genes coding for the tumor necrosis factor and lymphotoxin ligand-receptor system in non-Hodgkin's lymphomas
Authors: Warzocha, K Ribeiro, P Renard, N Bienvenu, J Charlot, C Coiffier, B Salles, G
Citation: K. Warzocha et al., Expression of genes coding for the tumor necrosis factor and lymphotoxin ligand-receptor system in non-Hodgkin's lymphomas, CANCER IMMU, 49(9), 2000, pp. 469-475
Abdominal cancer with peritoneal carcinomatosis treated by peritonectomy procedure and intraperitoneal chemohyperthermia
Authors: Glehen, O Peyrat, P Beaujard, A Caillot, JL Francois, Y Gueugniaud, PY Garbit, F Bienvenu, J Vignal, J Gilly, FN
Citation: O. Glehen et al., Abdominal cancer with peritoneal carcinomatosis treated by peritonectomy procedure and intraperitoneal chemohyperthermia, EXP ONCOL, 22(1-2), 2000, pp. 59-63
Intraperitoneal chemohyperthermia with mitomycin C for digestive tract cancer patients with peritoneal carcinomatosis
Authors: Beaujard, AC Glehen, O Caillot, JL Francois, Y Bienvenu, J Panteix, G Garbit, F Grandclement, E Vignal, J Gilly, FN
Citation: Ac. Beaujard et al., Intraperitoneal chemohyperthermia with mitomycin C for digestive tract cancer patients with peritoneal carcinomatosis, CANCER, 88(11), 2000, pp. 2512-2519
A novel missense mutation (C30S) in the gene encoding tumor necrosis factor receptor 1 linked to autosomal-dominant recurrent fever with localized myositis in a French family
Authors: Dode, C Papo, T Fieschi, C Pecheux, C Dion, E Picard, F Godeau, P Bienvenu, J Piette, JC Delpech, M Grateau, G
Citation: C. Dode et al., A novel missense mutation (C30S) in the gene encoding tumor necrosis factor receptor 1 linked to autosomal-dominant recurrent fever with localized myositis in a French family, ARTH RHEUM, 43(7), 2000, pp. 1535-1542
Serum levels of YKL-40 and C reactive protein in patients with hip osteoarthritis and healthy subjects: a cross sectional study
Authors: Conrozier, T Carlier, MC Mathieu, P Colson, F Debard, AL Richard, S Favret, H Bienvenu, J Vignon, E
Citation: T. Conrozier et al., Serum levels of YKL-40 and C reactive protein in patients with hip osteoarthritis and healthy subjects: a cross sectional study, ANN RHEUM D, 59(10), 2000, pp. 828-831
Detection of basophil activation by flow cytometry in patients with allergy to muscle-relaxant drugs
Authors: Monneret, G Benoit, Y Gutowski, MC Bienvenu, J
Citation: G. Monneret et al., Detection of basophil activation by flow cytometry in patients with allergy to muscle-relaxant drugs, ANESTHESIOL, 92(1), 2000, pp. 275-277
Evaluation of an automated immunoassay method for cytokine measurement using the Immulite (R) immunoassay system
Authors: Berthier, F Lambert, C Genin, C Bienvenu, J
Citation: F. Berthier et al., Evaluation of an automated immunoassay method for cytokine measurement using the Immulite (R) immunoassay system, CLIN CH L M, 37(5), 1999, pp. 593-599
Multicenter evaluation study on a new HEp2 ANA screening enzyme immune assay
Authors: Bayer, PM Bauerfeind, S Bienvenu, J Fabien, N Frei, PC Gilburd, B Heide, KG Hoier-Madsen, M Meroni, PL Monier, JC Monneret, G Panzeri, P Shoenfeld, Y Spertini, F Wiik, A
Citation: Pm. Bayer et al., Multicenter evaluation study on a new HEp2 ANA screening enzyme immune assay, J AUTOIMMUN, 13(1), 1999, pp. 89-93
Autoantibodies directed against the ribosomal P proteins are not only directed against a common epitope of the P0, P1 and P2 proteins
Authors: Fabien, N Moreira, A Lavergne, JP Desbos, A Surgey, P de Olivera, CA Gonzalo, P Venot, A Bienvenu, J Perrier, H Reboud, JP Monier, JC
Citation: N. Fabien et al., Autoantibodies directed against the ribosomal P proteins are not only directed against a common epitope of the P0, P1 and P2 proteins, J AUTOIMMUN, 13(1), 1999, pp. 103-110
Profiles and prognostic values of LDH isoenzymes in patients lymphoma
Authors: Dumontet, C Drai, J Bienvenu, J Berard, EN Thieblemont, C Bouafia, F Bayle, F Moullet, I Salles, G Coiffier, B
Citation: C. Dumontet et al., Profiles and prognostic values of LDH isoenzymes in patients lymphoma, LEUKEMIA, 13(5), 1999, pp. 811-817
Procalcitonin is not produced by circulating blood cells
Authors: Monneret, G Laroche, B Bienvenu, J
Citation: G. Monneret et al., Procalcitonin is not produced by circulating blood cells, INFECTION, 27(1), 1999, pp. 34-35
Peritonectomy combined with intraperitoneal chemohyperthermia in abdominalcancer with peritoneal carcinomatosis: Phase I-II study
Authors: Gilly, FN Beaujard, A Glehen, O Grandclement, E Caillot, JL Francois, Y Sadeghi-Looyeh, B Gueugniaud, PY Garbit, F Benoit, M Bienvenu, J Vignal, J
Citation: Fn. Gilly et al., Peritonectomy combined with intraperitoneal chemohyperthermia in abdominalcancer with peritoneal carcinomatosis: Phase I-II study, ANTICANC R, 19(3B), 1999, pp. 2317-2321
Intraperitoneal chemo-hyperthermia with mitomycin C for gastric cancer patients with peritoneal carcinomatosis
Authors: Sayag-Beaujard, AC Francois, Y Glehen, O Sadeghi-Looyeh, B Bienvenu, J Panteix, G Garbit, F Grandclement, E Vignal, J Gilly, FN
Citation: Ac. Sayag-beaujard et al., Intraperitoneal chemo-hyperthermia with mitomycin C for gastric cancer patients with peritoneal carcinomatosis, ANTICANC R, 19(2B), 1999, pp. 1375-1382
Gene therapy with AdV-IL-2 in unresectable digestive cancer: Phase I-II study, intermediate report
Authors: Gilly, FN Beaujard, A Bienvenu, J Lenoir, VT Glehen, O Thouvenot, D Malcus, C Favrot, M Dumontet, C Lomhard-Bohas, C Garbit, F Gueugniaud, PY Vignal, J Aymard, M Moulin, FT Roos, M Pavirani, A Courtney, M
Citation: Fn. Gilly et al., Gene therapy with AdV-IL-2 in unresectable digestive cancer: Phase I-II study, intermediate report, HEP-GASTRO, 46, 1999, pp. 1268-1273
Fas and Fas ligand expression in cystic fibrosis airway epithelium
Authors: Durieu, I Amsellem, C Paulin, C Chambe, MT Bienvenu, J Ballon, G Pacheco, Y
Citation: I. Durieu et al., Fas and Fas ligand expression in cystic fibrosis airway epithelium, THORAX, 54(12), 1999, pp. 1093-1098
Laboratory data in healthy volunteers: reference values, reference changes, screening and laboratory adverse event limits in phase I clinical trials
Authors: Sibille, M Deigat, N Durieu, I Guillaumont, M Morel, D Bienvenu, J Massignon, D Durand, DV
Citation: M. Sibille et al., Laboratory data in healthy volunteers: reference values, reference changes, screening and laboratory adverse event limits in phase I clinical trials, EUR J CL PH, 55(1), 1999, pp. 13-19
Risultati: 1-25 | 26-29